Biogen’s applications for the higher dose regimen of SMA drug Spinraza are now under review in the US and Europe.
Spinraza remains a big product for Biogen, but has seen its sales go into reverse as competition in SMA treatment has emerged ...
The parents of two-year-old Aakriti Singh diagnosed with Spinal Muscular Atrophy – SMA type-1, are worried about her next ...
However, the eligible patient population indicated for Novartis' Zolgensma is limited ... s once-quarterly IT administration of Spinraza (nusinersen) and Roche’s once-daily Evrysdi (risdiplam).
However, the eligible patient population indicated for Novartis’ Zolgensma is limited ... These include Biogen’s once-quarterly IT administration of Spinraza (nusinersen) and Roche’s once-daily ...
Currently three treatments are available for SMA patients – Onasemnogene abeparvovec-xioi (Zolgensma) a gene therapy for treating children below two years of age, Nusinersen (Spinraza ...
South Africa 615 (Rickelton, Bavuma 106, Verreynne 100, Abbas 3-94) and 61 for no loss (Bedingham 47*) beat Pakistan 194 (Babar 58, Rabada 3-55) and 478 (Masood 145, Babar 81, Rabada 3-115) by ten ...
Treatment with OAV101 IT, a formulation of the gene therapy Zolgensma (onasemnogene abeparvovec-xioi) that’s delivered directly into the spinal canal, safely led to motor improvements for children ...
Joao Pedro won and converted a penalty after William Saliba made contact with the forward's head as they contested a high ball; the Arsenal defender made a slight touch with the ball before ...